Target intelligence / Profile preview

FCHO2 divergent transcript (FCHO2-DT)

Target: FCHO2-DT
Molecular classification: Other (non-coding RNA; divergent transcript)

Overview

FCHO2 divergent transcript (FCHO2-DT, TCONS_00010375) is a non-coding RNA identified as transcribed in the locus near or antisense to the FCHO2 gene, which encodes a membrane-associated protein involved in clathrin-mediated endocytosis. Divergent transcripts like FCHO2-DT are typically transcribed in the opposite direction from nearby protein-coding genes due to promoter architecture and chromatin organization, observed in human and other mammalian genomes. No experimental evidence clarifies its function, direct involvement in drug targeting, disease roles, or protein-coding potential.

Other names: TCONS_00010375FCHO2-DT

Beyond the preview

Go deeper on FCHO2 divergent transcript (FCHO2-DT).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on FCHO2 divergent transcript (FCHO2-DT).

Explore the full profile